Clinical study on mesothelioma in Japan: Relevance to occupational asbestos exposure

American Journal of Industrial Medicine

Volumn 53, Issue 11, 2010, Pages 1081-1087

  Kishimoto, Takumi ^a   Gemba, Kenichi ^a   Fujimoto, Nobukazu ^a   Aoe, Keisuke ^b   Kato, Katsuya ^c   Takeshima, Yukio ^d   Inai, Kohki ^d  

^a OKAYAMA ROSAI HOSPITAL   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Asbestos particles; Exposure; Helsinki criteria; Mesothelioma; Pleural plaques

Indexed keywords

ASBESTOS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; FEMALE; HUMAN; JAPAN; KAPLAN MEIER METHOD; MALE; MEDICAL RECORD; MESOTHELIOMA; MIDDLE AGED; MORTALITY; NEOPLASM; OCCUPATIONAL EXPOSURE; QUESTIONNAIRE; RETROSPECTIVE STUDY; WORKMAN COMPENSATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MEDICAL RECORDS; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS; OCCUPATIONAL EXPOSURE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; WORKERS' COMPENSATION; YOUNG ADULT;

EID: 77958501808     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20868     Document Type: Article

References (14)

1. Bianchi C, Bianchi T. 2007. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind Health 45: 379-387.
2. Consensus Report. 1997. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 23: 311-316.
3. Inai K. 2005. Asbestos related diseases from a pathology viewpoint. In: Morinaga K, editor. Asbestos exposure and asbestos diseases-Fundamental knowledge, compensation, and relief. Tokyo, Japan: Sanshin Tosho. p 237-264.
4. Kishimoto T. 1992. Intensity of asbestos exposure in metropolitan Kure areas. Cancer 69: 2598-2602.
5. Kishimoto T, Ozaki S, Kato K, Nishi H, Gemba K. 2004. Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. Ind Health 42: 435-439.
6. Kohyama N. 2008. Asbestos particles and asbestos fibers. In: Morinaga K, editor. Asbestos exposure and asbestos diseases-Fundamental knowledge, compensation, and relief. Tokyo, Japan: Sanshin Tosho. p 69-87.
7. Kohyama N, Hoshino K. 2008. Usefulness of asbestos and its applications in Japan. In: Morinaga K, editor. Asbestos exposure and asbestos diseases-Fundamental knowledge, compensation, and relief. Tokyo, Japan: Sanshin Tosho. p 25-40.
8. Kradin RL, Mark EJ. 2006. Distinguishing benign mesothelial hyperplasia from neoplasia: A practical approach. Semin Diagn Pathol 23: 4-14.
9. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. 2008. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry. Pathol Int 58: 75-83.
10. Lyons-Boudreax V, Mody DR, Coffey D. 2008. Cytologic malignancy versus benigncy. How useful are the "newer markers in body fluid cytology"? Arch Pathol Lab Med 132: 23-28.
11. Murayama T, Takahashi K, Natori Y, Kurumatani N. 2006. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49: 1-7.
12. Ordonez NG. 2003. The immunohistochemical diagnosis of mesothelioma. A comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27: 1031-1051.
13. Ordonez NG. 2006. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum. A review and update. Adv Anat Pathol 13: 16-25.
14. Ordonez NG. 2007. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 38: 1-16.